NEU neuren pharmaceuticals limited

Ann: Neuren reports 2023 half-year profit after tax of $48m, page-4

  1. 2,170 Posts.
    lightbulb Created with Sketch. 572
    Hi Holidays,

    Would understand perhaps milestones payments couldn't be used forward looking, but profit after tax is in the bank.

    Couldn't see a more accurate way to establish a EPS especially in NEU's case being undervalued and experiencing huge growth!

    The milestone payments aren't really 1 offs either there is $1bn in milestone payments in Neu licensing agreements, we could get 3 this FY if Acadia does 1st sales in ROW, and they will likely occur every year for a few years assuming thresholds met in ROW and US.

    This is very significant revenue to our bottom line it has to be measured and reflective in share price or market cap.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
0.000(0.00%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.48 $16.77 $16.28 $3.108M 188.0K

Buyers (Bids)

No. Vol. Price($)
1 105 $16.48
 

Sellers (Offers)

Price($) Vol. No.
$16.54 885 2
View Market Depth
Last trade - 16.13pm 28/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.